These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7324079)

  • 61. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.
    Ahn SH; Park YN; Park JY; Chang HY; Lee JM; Shin JE; Han KH; Park C; Moon YM; Chon CY
    J Hepatol; 2005 Feb; 42(2):188-94. PubMed ID: 15664243
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
    Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
    J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immune complex levels and HBs-antigenaemia in healthy Nigerians and patients with liver diseases.
    Okerengwo AA; Atoba MA
    Afr J Med Med Sci; 1992 Dec; 21(2):35-8. PubMed ID: 1308079
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status.
    Honda A; Yokosuka O; Ehata T; Tagawa M; Imazeki F; Saisho H
    J Med Virol; 1999 Apr; 57(4):337-44. PubMed ID: 10089043
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it.
    Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y
    Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The significance of HB antigenemy in apparently healthy persons in the clinic for liver diseases.
    Lesnicar J; Zaversnik H; Ferluga D; Krk C
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):297-304. PubMed ID: 1199669
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
    Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
    Liver Int; 2005 Jun; 25(3):564-70. PubMed ID: 15910494
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Detection of delta, core and surface antigens in the liver of chronic HBsAg carriers.
    Picciotto A; Bastardini R; Boscarino S; Lapertosa G; Mansi C; Savarino V; Celle G
    Pathologica; 1983; 75(1035):121-5. PubMed ID: 6348677
    [No Abstract]   [Full Text] [Related]  

  • 75. [Chronic active hepatitis and pregnancy. A case report and review of the literature (author's transl)].
    Guerre J; Gaudric M; Louis P; Bars L
    Ann Med Interne (Paris); 1981; 132(6):394-7. PubMed ID: 7316306
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HBs antigen subtypes among acute hepatitis patients in Japan: evidence of imported hepatitis.
    Shiina S; Fujino H; Yasuda H; Kawabe T; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S
    Am J Gastroenterol; 1988 Jul; 83(7):727-9. PubMed ID: 3381803
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Duration of hepatitis B surface antigenemia (HBs Ag) in hemodialysis patients.
    Ribot S; Rothstein M; Goldblat M; Grasso M
    Arch Intern Med; 1979 Feb; 139(2):178-80. PubMed ID: 434972
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Microscopic, immunochemical and ultrastructral study of livers histologically normal or subnormal in patients with hepatitis B surface antigen (HBs). Report of 18 cases (author's transl)].
    Tamboise E; Camilleri JP; Boddaert A; Slama JL; Paraf A
    Pathol Biol (Paris); 1979 May; 27(5):285-92. PubMed ID: 92003
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Behavior of HBs Ag and HBs Ab in chronic hepatitis].
    De Bellis G; Di Martino G; Russo N
    Boll Ist Sieroter Milan; 1976; 55(2):164-7. PubMed ID: 1023884
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Prognosis of acute hepatitis B].
    Malacco E; Iacono G; Risso F
    Minerva Med; 1979 Feb; 70(8):575-81. PubMed ID: 431875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.